Samsung Medical Center
Bone cancer treatment cost in the Republic of Korea runs from $8,200 to $22,000 for primary surgical interventions, while essential PET-CT scans cost $900 to $1,400. Total expenses depend on the malignancy stage, required chemotherapy cycles, and the hospital tier. Patients typically find oncology services 30% to 75% less expensive than in the US. Top treatment centers are primarily located in Seoul and Incheon.
Typical Bone Cancer Treatment Costs in Republic of Korea
Bookimed Expert Insight: For complex oncological cases, choosing large-scale multidisciplinary centers is the most effective approach. Seoul National University Hospital (SNUH) is a leading state facility with the highest cancer treatment statistics in South Korea. Patients requiring advanced technology should consider Samsung Medical Center, which uses the Da Vinci surgical system and IGRT. Korea University Anam Hospital is best for those seeking minimal scarring via robotic surgery.
| Republic of Korea | Turkey | Austria | |
| Chemotherapy for breast cancer | from $19,200 | from $1,200 | from $15,000 |
| Bone deformity correction surgery | from $8,200 | from $2,500 | from $30,000 |
| Radiation therapy for colorectal cancer | - | from $7,000 | from $12,000 |
| Halcyon | - | from $5,400 | - |
| Bone resection | - | from $8,000 | from $25,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Bone cancer treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Bone cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Bone cancer treatment journey.
The doctor is a highly experienced Orthopaedic and Joint Replacement Surgeon with over 41 years of expertise. Specializing in arthritis, knee and sports injuries, hip joint issues, pelvic bone and hip fractures, osteosarcoma, pelvic bone tumors, soft tissue sarcomas, congenital clubfoot, and foot deformities, the doctor has made significant contributions to the field.
Graduating from Seoul National University College of Medicine, the doctor earned an M.D. in Orthopedic Surgery in 1983 and a Ph.D. in 1994. The doctor has completed numerous research projects and published extensively in peer-reviewed journals both nationally and internationally.
The doctor is a highly experienced Hematologist-Oncologist with over 26 years of expertise in the field. Specializing in the treatment of colon cancer, hematological oncology, myelomas, and lymphoma, the doctor is proficient in advanced procedures such as Bone Marrow Transplantation, including Alternate Donor and Mismatched Transplants.
With a strong academic background, the doctor holds an M.D. from Yonsei University College of Medicine and a Ph.D. from Sungkyunkwan University College of Medicine. The doctor is also a member of multiple professional societies and has contributed to the field through numerous paper publications.
The doctor is an expert in oncoplastic surgery and breast cancer, with extensive experience from prestigious institutions. The doctor holds an M.D. degree from Seoul National University College of Medicine and an M.S. degree in Surgery from the same institution. Additionally, the doctor earned a B.S. in biological sciences from the Korea Advanced Institute of Science and Technology (KAIST) and a Ph.D. in Surgery from Seoul National University Graduate School.
The doctor is a prominent figure in the field of surgery, holding leadership roles such as Director of the Training and Education Committee at the Korean Surgical Society and Director of the Information Technology Committee at the Korean Society of Coloproctology. The doctor also serves as Director of the Surgical Affairs Board at the Korean Society of Gastroenterology and Vice President of the Korean Association of Robotic Surgeons.
With a robust educational background from Korea University, the doctor has demonstrated surgical expertise internationally, including at the Faculty of Medicine, Chinese University of Hong Kong, and Tan Tock Seng Hospital in Singapore.
South Korea provides advanced bone cancer treatments focused on limb preservation and biological reconstruction. Specialized centers utilize heavy ion therapy, robotic surgery, and multidisciplinary tumor boards. These JCI-accredited facilities integrate neoadjuvant chemotherapy with surgical precision to maximize functional outcomes for sarcoma patients.
Bookimed Expert Insight: While many countries offer oncology, South Korea stands out for functional recovery. Clinics like Seoul National University Hospital and Samsung Medical Center serve over 1,500,000 patients annually. This massive volume allows specialists to refine niche reconstruction techniques that general hospitals rarely perform.
Patient Consensus: Patients prioritize finding orthopedic oncologists who specialize in limb-sparing resection rather than amputation. They often seek second opinions at large university hospitals to ensure they achieve the best possible walking ability and long-term rehabilitation.
South Korea reports a 5-year survival rate for localized bone cancer between 60% and 75%. Success rates reach 80% to 90% for low-grade chondrosarcoma. Leading facilities like Seoul National University Hospital employ limb-salvage protocols to preserve function and avoid amputation during tumor removal.
Bookimed Expert Insight: Korea University Anam Hospital specializes in bloodless surgery and robotic techniques for oncology. This focus on precision often leads to faster recovery after complex sarcoma resections. Their expertise in limb-salvage surgery supports high survival while maintaining the patient's quality of life.
Patient Consensus: Patients emphasize finding a specialized team with sarcoma experience is vital. The focus often shifts from simple survival to achieving successful limb salvage and long-term functional mobility.
Top South Korean hospitals for bone cancer treatment include Samsung Medical Center, Seoul National University Hospital, Asan Medical Center, and Severance Hospital. These Joint Commission International (JCI) accredited facilities utilize multidisciplinary musculoskeletal tumor centers. They specialize in complex limb-salvage surgeries and advanced diagnostic imaging.
Bookimed Expert Insight: While many facilities offer orthopedic services, SNUH and Severance Hospital stand out for their century-long history. These institutions pioneered bone cancer care in Korea. Our data shows SNUH serves 10,700 patients daily. This massive volume ensures surgeons maintain high expertise in rare sarcoma variants.
Patient Consensus: Patients note that the best outcomes for rare bone cancers come from specialized sarcoma teams in Seoul. They emphasize seeking hospitals that combine surgery, radiation, and pathology under one roof.